Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Maria Ravaioli

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
European Journal of Dermatology : EJD|May 20, 2017
Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective studyEmi Dika, Giulia Maria Ravaioli, Pier Alessandro Fanti, et al.
European Journal of Dermatology : EJD|May 20, 2017
Oestrogen and progesterone receptors in melanoma and nevi: an immunohistochemical studyEmi Dika, Pier Alessandro Fanti, Sabina Vaccari, et al.
American Journal of Clinical Pathology|February 5, 2020
BRAF, KIT, and NRAS Mutations of Acral Melanoma in White PatientsEmi Dika, Giulia Veronesi, Annalisa Altimari, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
European Journal of Dermatology : EJD|May 20, 2017
Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective studyEmi Dika, Giulia Maria Ravaioli, Pier Alessandro Fanti, et al.
European Journal of Dermatology : EJD|May 20, 2017
Oestrogen and progesterone receptors in melanoma and nevi: an immunohistochemical studyEmi Dika, Pier Alessandro Fanti, Sabina Vaccari, et al.
American Journal of Clinical Pathology|February 5, 2020
BRAF, KIT, and NRAS Mutations of Acral Melanoma in White PatientsEmi Dika, Giulia Veronesi, Annalisa Altimari, et al.
Pageof 4